News
TÜBINGEN, Germany, April 29, 2025 /PRNewswire/ -- Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study ...
Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study , evaluating ACOU085 (INN: ...
Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study , evaluating ACOU085 (INN: bimokalner) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback